AU2001239827A1 - Substituted alkylene diamine compounds - Google Patents
Substituted alkylene diamine compoundsInfo
- Publication number
- AU2001239827A1 AU2001239827A1 AU2001239827A AU3982701A AU2001239827A1 AU 2001239827 A1 AU2001239827 A1 AU 2001239827A1 AU 2001239827 A AU2001239827 A AU 2001239827A AU 3982701 A AU3982701 A AU 3982701A AU 2001239827 A1 AU2001239827 A1 AU 2001239827A1
- Authority
- AU
- Australia
- Prior art keywords
- substituted alkylene
- diamine compounds
- alkylene diamine
- compounds
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/58—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
- C07D317/64—Oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18413200P | 2000-02-22 | 2000-02-22 | |
| US60184132 | 2000-02-22 | ||
| PCT/US2001/005655 WO2001062711A2 (en) | 2000-02-22 | 2001-02-22 | Substituted alkylene diamine compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001239827A1 true AU2001239827A1 (en) | 2001-09-03 |
Family
ID=22675672
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001239827A Abandoned AU2001239827A1 (en) | 2000-02-22 | 2001-02-22 | Substituted alkylene diamine compounds |
Country Status (3)
| Country | Link |
|---|---|
| US (1) | US6638970B2 (en) |
| AU (1) | AU2001239827A1 (en) |
| WO (1) | WO2001062711A2 (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL159897A0 (en) * | 2001-07-19 | 2004-06-20 | Cv Therapeutics Inc | Substituted piperazine compounds and their use as fatty acid oxidation inhibitors |
| CA2508608A1 (en) * | 2002-12-05 | 2004-06-24 | Cv Therapeutics, Inc. | Substituted piperazine compounds and their use as fatty acid oxidation inhibitors |
| EP1806346B1 (en) * | 2002-12-05 | 2009-07-22 | Cv Therapeutics, Inc. | Substituted piperazine compounds and their use as fatty acid oxidation inhibitors |
| ATE443058T1 (en) * | 2003-01-03 | 2009-10-15 | Cv Therapeutics Inc | SUBSTITUTED HETEROCYCLIC COMPOUNDS |
| JP2006515891A (en) * | 2003-01-17 | 2006-06-08 | シーブイ・セラピューティクス・インコーポレイテッド | Substituted heterocyclic compounds effective for the treatment of cardiovascular diseases |
| WO2005000826A1 (en) * | 2003-06-23 | 2005-01-06 | Cv Therapeutics, Inc. | Urea derivatives of piperazines and piperidines as fatty acid oxidation inhibitors |
| EP1789407A2 (en) * | 2004-09-08 | 2007-05-30 | Cv Therapeutics, Inc. | Substituted piperazine compounds and their use as fatty acid oxidation inhibitors |
| WO2007053415A2 (en) * | 2005-11-01 | 2007-05-10 | Novartis Vaccines And Diagnostics Inc. | Agents for the treatment of cardiac arrhythmias |
| US20100303753A1 (en) * | 2007-10-19 | 2010-12-02 | Nektar Therapeutics | Oligomer Conjugates of Lidocaine and Its Derivatives |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2267104A1 (en) | 1974-04-12 | 1975-11-07 | Ferlux Labo Sa | Hypotensive and antiarrhythmic piperazines - 1-(3-phenoxy-2-hydroxy propyl)-4-substd. piperazines |
| GB1540463A (en) | 1976-10-07 | 1979-02-14 | Ici Ltd | Alkanolamine derivatives |
| US4766125A (en) | 1981-06-23 | 1988-08-23 | Janssen Pharmaceutica N.V. | N-aryl-piperazinealkanamides useful for protecting hearts from myocardial injury caused by ischaemia, anoxia or hypoxia |
| US4567264A (en) | 1983-05-18 | 1986-01-28 | Syntex (U.S.A.) Inc. | Cardioselective aryloxy- and arylthio- hydroxypropylene-piperazinyl acetanilides which affect calcium entry |
| ATE142497T1 (en) * | 1989-06-23 | 1996-09-15 | Syntex Inc | RANOLAZINE AND RELATED PIPERAZINES FOR THE TREATMENT OF TISSUES AFFECTED BY PHYSICAL OR CHEMICAL DAMAGE |
| US5527545A (en) | 1989-09-18 | 1996-06-18 | Recordati S.A. Chemical And Pharmaceutical Company | Liquid-suspension controlled-release pharmaceutical composition |
| JPH03141258A (en) | 1989-10-25 | 1991-06-17 | Kowa Co | Novel piperazine derivative |
| DK203990D0 (en) | 1990-08-24 | 1990-08-24 | Novo Nordisk As | piperazinyl |
| HU209723B (en) | 1990-10-31 | 1994-10-28 | Richter Gedeon Vegyeszet | Process for producing of piperazine derivatives |
| US5455045A (en) | 1993-05-13 | 1995-10-03 | Syntex (U.S.A.) Inc. | High dose formulations |
-
2001
- 2001-02-22 AU AU2001239827A patent/AU2001239827A1/en not_active Abandoned
- 2001-02-22 US US09/790,932 patent/US6638970B2/en not_active Expired - Fee Related
- 2001-02-22 WO PCT/US2001/005655 patent/WO2001062711A2/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001062711A3 (en) | 2002-02-14 |
| US20010036961A1 (en) | 2001-11-01 |
| WO2001062711A2 (en) | 2001-08-30 |
| US6638970B2 (en) | 2003-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001234128A1 (en) | Novel imidazoline compounds | |
| AU2002218266A1 (en) | Novel indanylidene compounds | |
| AU2002225730A1 (en) | Compounds | |
| AU7476301A (en) | Novel compounds | |
| AU2001292518A1 (en) | Novel compounds | |
| EP1276755A4 (en) | Novel compounds | |
| AU9261901A (en) | Novel compounds | |
| AUPQ661800A0 (en) | Insulin-potentiating compounds | |
| AU2001239765A1 (en) | Novel compounds | |
| AU2001246998A1 (en) | Novel compounds | |
| EP1292617A4 (en) | Novel compounds | |
| AU2001253362A1 (en) | Novel compounds | |
| AU2002231077A1 (en) | Novel compounds | |
| AU2001256964A1 (en) | Novel compounds | |
| AU7476401A (en) | Novel compounds | |
| AU2001239827A1 (en) | Substituted alkylene diamine compounds | |
| AU2002225724A1 (en) | Motilide compounds | |
| AU2002217285A1 (en) | Compounds | |
| AU2001230689A1 (en) | Novel compounds | |
| AU2002221923A1 (en) | Novel compounds | |
| AU2002216060A1 (en) | Novel compounds | |
| AU2001276890A1 (en) | Novel compounds | |
| AU2001237533A1 (en) | Novel p-gp-inhibiting compounds | |
| AU2001258760A1 (en) | Novel thiophenamide compounds | |
| AU2001279612A1 (en) | Substituted polyamine compounds |